Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.735
-0.085 (-1.76%)
At close: Nov 20, 2024, 4:00 PM
4.730
-0.005 (-0.11%)
After-hours: Nov 20, 2024, 5:49 PM EST
Aquestive Therapeutics Employees
Aquestive Therapeutics had 135 employees as of December 31, 2023. The number of employees increased by 5 or 3.85% compared to the previous year.
Employees
135
Change (1Y)
5
Growth (1Y)
3.85%
Revenue / Employee
$436,296
Profits / Employee
-$260,689
Market Cap
431.73M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Quanterix | 441 |
National Research | 435 |
Allogene Therapeutics | 233 |
Rigel Pharmaceuticals | 147 |
Foghorn Therapeutics | 116 |
Korro Bio | 102 |
Aura Biosciences | 89 |
Taysha Gene Therapies | 52 |
AQST News
- 11 days ago - Undercovered Dozen: Asbury Automotive, Globalstar, Northland Power, Aquestive Therapeutics + - Seeking Alpha
- 15 days ago - Aquestive Therapeutics, Inc. (AQST) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Aquestive: Rare Opportunity With Dual Platform Strategy - Seeking Alpha
- 16 days ago - Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day - GlobeNewsWire
- 2 months ago - Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th - GlobeNewsWire
- 3 months ago - Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings - Seeking Alpha
- 3 months ago - Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire